Sanofi (NASDAQ:SNY) Shares Sold by Asset Dedication LLC

Asset Dedication LLC decreased its holdings in shares of Sanofi (NASDAQ:SNY) by 68.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,248 shares of the company’s stock after selling 2,654 shares during the quarter. Asset Dedication LLC’s holdings in Sanofi were worth $60,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Northwest Investment Counselors LLC acquired a new stake in shares of Sanofi during the 3rd quarter worth approximately $29,000. Concord Wealth Partners grew its stake in Sanofi by 157.8% during the 3rd quarter. Concord Wealth Partners now owns 593 shares of the company’s stock worth $34,000 after buying an additional 363 shares during the last quarter. Fortitude Family Office LLC increased its position in Sanofi by 708.6% in the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after buying an additional 659 shares during the period. Sunbelt Securities Inc. lifted its stake in Sanofi by 72.1% in the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after buying an additional 313 shares during the last quarter. Finally, Versant Capital Management Inc acquired a new position in shares of Sanofi during the fourth quarter valued at $54,000. Institutional investors own 14.04% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on SNY shares. StockNews.com downgraded shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Deutsche Bank Aktiengesellschaft raised Sanofi from a “sell” rating to a “hold” rating in a report on Thursday. Two analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $60.00.

Sanofi Stock Performance

SNY stock opened at $54.15 on Friday. The company has a market capitalization of $137.42 billion, a P/E ratio of 27.63, a PEG ratio of 1.19 and a beta of 0.57. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The company has a 50-day simple moving average of $49.12 and a 200 day simple moving average of $52.24. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $58.97.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. Sell-side analysts predict that Sanofi will post 3.82 earnings per share for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.